City of Hope obtains United States patent.(City of Hope National Medical Center)(Brief article)

BIOTECH Patent News, August, 2007

City of Hope (Duarte, CA) has patented genetically engineered, CE7-specific redirected immune cells expressing a cell surface protein having an extracellular domain comprising a receptor which is specific for CE7, an intracellular signaling domain, and a transmembrane domain, and methods of use for such cells for cellular immunotherapy of CE7 neuroblastoma are disclosed.

In one embodiment, the immune cell is a T cell and the cell surface protein is a single chain FvFc: .zeta. receptor where Fv designates the V.sub.H and V.sub.L chains of a single chain monoclonal antibody to CE7 linked by peptide, F.sub.c represents a hinge-C.sub.H2-C.sub.H3 region of a human IgG.sub.1, and .zeta. represents the intracellular signaling domain of the zeta chain of human CD3. DNA...

Read the rest of this article with a Free Trial at HighBeam Research.

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works.